A study by Jim Hu, M.D., and colleagues has found that the rate of prostate biopsies and radical prostatectomies decreased following a 2012 United States Preventative Task Force recommendation against prostate specific antigen (PSA) testing. Read more
Olivier Elemento, Ph.D., and Mark Rubin, M.D., penned a guest piece in Oncology Times about genomics in oncology and the role of precision medicine Read more
Personalized medicine is getting a boost at Weill Cornell Medicine with an online genomics databank that uses an API to integrate insights into the clinical workflow. Read more
Dan Landau, M.D., Ph.D. speaks about clonal evolution in chronic lymphocytic leukemia (CLL), after his talk at the 2016 International Workshop of the German CLL Study Group in Cologne, Germany. Read more
Inflammation of white adipose tissue may be a better predictor of breast cancer incomes than body mass index, according to Andrew Dannenberg, M.D. Read more
There has been an overemphasis on the genomic component of precision medicine, according to Mark Rubin, M.D., director of the Englander Institute for Precision Medicine. Read more
Eftychia Apostolou, Ph.D., has won a New Innovator Award from the National Institutes of Health for her research on how cells preserve their identity under normal conditions or alter it during pathogenesis Read more
While chemotherapy kills the most common type of bladder cancer, urothelial cancer, it also shapes the genetic evolution of remaining urothelial cancer cell clones to become drug-resistant, according to Bishoy Faltas and colleagues. Read more